CTOs on the Move


 
JenCare Senior Medical Centers are family-owned primary and specialty care practices committed to delivering superior healthcare to Medicare-eligible seniors. Our care model now serves tens of thousands of seniors all across the country. And we`ll continue to expand to offer more seniors access to the quality healthcare they deserve.
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Medavie EMS

Medavie EMS is a health care delivery and management company based in Dartmouth, Nova Scotia, Canada.  We have a team of management staff that specializes in the areas of project management, planning, education, human resources, communications finance, physical resources, process design, facilitation, reporting, and information technology.   Currently, Medavie EMS is responsible to deliver EMS in Nova Scotia, New Brunswick, Prince Edward Island, the District Municipality of Muskoka in Ontario, the Municipality of Chatham-Kent in Ontario, Elgin County in Ontario, Saskatoon and surrounding areas in Saskatchewan, as well as, communities across eastern Alberta.  Each of these systems is managed by subsidiary companies which have established contracts with governments (provincial and municipal) or health authorities.   In addition, Medavie EMS operates a patient transfer service in Massachusetts headquartered in Boston.  Combined these companies directly employ or manage a total staff of approximately 3800, 550 of whom are in the US.

CEA Technologies

CEA Technologies is a Colorado Springs, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sybron Dental Specialties, Inc.

Sybron Dental Specialties, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Anaheim, CA. To find more information about Sybron Dental Specialties, Inc., please visit www.sybrondental.com

Z-SC1 Biomedical

Z-SC1 Biomedical is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.